INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$90K
2,440 sh
Jan 5, 2026Jan 6, 2026
Page 1572 of 1855
← PrevNext →
traded Jan 5, 2026
+1d
SEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
1,936 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$421K
1,748 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
CA
Colglazier Michael ADirector
FUNSix Flags Entertainment Corporation/NEW
Grant or award
A—
13.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
BD
Bragg David D.SVP - Chief Financial Officer
UDRUDR, Inc.
Grant or award
A—
87.4K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
3,344 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

20
MS
Mumenthaler Christian StephaneDirector
METMETLIFE INC
Grant or award
A$51K
639 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

20
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Tax withholding
F$111K
6,373 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

19
TR
Turvey Paul RobertSVP & Assoc. General Counsel
EPREPR PROPERTIES
Tax withholding
F$277K
5,548 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

19
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Option exercise
M—
12 sh
Jan 1, 2026Jan 6, 2026
traded Jan 1, 2026
+5dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
400 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
2,595 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$45K
1,186 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
1,300 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$189K
2,828 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$45K
1,222 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
941 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$93K
2,405 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$462K
2,577 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
RJ
Roberts Malcolm JamesEVP & Chief Commercial Officer
BTUPEABODY ENERGY CORP
Grant or award
A—
8,148 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
RR
Rodriguez Joseph RyanChief Risk and Legal Officer
MVBFMVB FINANCIAL CORP
Tax withholding
F$44K
1,716 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
LT
Lovalekar TusharVP, Information Technology
KOPKoppers Holdings Inc.
Grant or award
A—
368 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
PA
Puwalski AllenDirector
NYSEFLGFLAGSTAR BANK, NATIONAL ASSOCIATION
Grant or award
A—
15.9K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Grant or award
A—
5,073 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
AV
Altamura Michelle VervaisEVP, General Counsel, Sec.
IRMIRON MOUNTAIN INC
Option exercise
M—
1,214 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$411K
2,304 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
SC
Swanton Robert CharlesDirector
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
3,726 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Grant or award
A—
4,562 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise
M—
19.7K sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

17
BS
Bowman Erica SVICE PRESIDENT
EIXEDISON INTERNATIONAL
Option exercise
M—
776 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
MA
Moriarty Brian AndrewSVP - Corporate Communications
EPREPR PROPERTIES
Grant or award
A—
4,835 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Grant or award
A—
155 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Grant or award
A—
20.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
LT
Lovalekar TusharVP, Information Technology
KOPKoppers Holdings Inc.
Tax withholding
F$55K
2,032 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

16
CJ
Carlson Anthony JDirector, President and CEO
ADARRAY DIGITAL INFRASTRUCTURE, INC.
Tax withholding
F$73K
1,355 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
300 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Tax withholding
F$182K
3,652 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
MD
Middleton Piers DayerEVP & Chief Operating Officer
TDWTIDEWATER INC
Tax withholding
F$107K
2,053 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
MA
Moriarty Brian AndrewSVP - Corporate Communications
EPREPR PROPERTIES
Tax withholding
F$71K
1,430 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
HJ
Hay Laura JDirector
METMETLIFE INC
Grant or award
A$51K
639 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence